Monte Rosa Therapeutics, Inc
The Research Associate will support the development and characterization of novel molecular glue degraders for inflammatory diseases within the Immunology and Preclinical Pharmacology team. The role involves designing, optimizing, and executing experiments with primary immune cells and tissues, as well as profiling compounds using various biochemical and cellular assays.
Monte Rosa Therapeutics is a biotechnology company pioneering molecular glue degrader (MGD) therapies that promote specific protein ubiquitination and subsequent proteasomal degradation of disease-causing, traditionally undruggable proteins. Their drug discovery platform integrates expertise in MGD chemistry, artificial intelligence, structural biology, and proteomics to rapidly advance programs targeting undruggable or inadequately drugged targets with unprecedented specificity. Focused on cancer and beyond, the company operates out of Boston, MA and Basel, Switzerland.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Monte Rosa Therapeutics, Inc.
Monte Rosa Therapeutics, Inc didn’t post a salary, so this is our estimate from similar listings.
5% below the average for this role
Biologist in Immunology Discovery Research
Eli Lilly and Company
Associate Scientist
ImmunEdge, Inc
Scientist, Bioscience Immunology
AstraZeneca
Scientist / Senior Scientist, Bioanalytical Sciences
Addition Therapeutics
Scientist I/II, In Vivo Pharmacology
Nurix
Principal Associate Scientist
Xaira Therapeutics